Nshunge Musheshe Selected Research

diethylstilbestrol monophosphate (PDES)

1/2019

Phosphodiesterases as therapeutic targets for respiratory diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nshunge Musheshe Research Topics

Disease

2	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 01/2021
2	Chemical and Drug Induced Liver Injury 11/2021 - 01/2021
2	Necrosis 11/2021 - 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2023
1	Alzheimer Disease (Alzheimer's Disease) 07/2023
1	Pain (Aches) 11/2021
1	Asthma (Bronchial Asthma) 01/2019
1	Bronchitis 01/2019
1	Inflammation (Inflammations) 01/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019

Drug/Important Bio-Agent (IBA)

2	erythromycin propionate-N-acetylcysteinateIBA 11/2021 - 01/2021
2	SYTOX GreenIBA 11/2021 - 01/2021
2	Diclofenac (SR 38)FDA LinkGeneric 11/2021 - 01/2021
2	Caspase 3 (Caspase-3)IBA 11/2021 - 01/2021
1	Amyloid beta-PeptidesIBA 07/2023
1	Metformin (Glucophage)FDA LinkGeneric 11/2021
1	Phosphodiesterase 4 InhibitorsIBA 01/2019
1	RoflumilastIBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	diethylstilbestrol monophosphate (PDES)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2021